Early research (Phase 1)Study completedNCT03635047What this trial is testingA Phase I Study for Safety and Tolerability of AL002.Who this might be right forHealthyAlzheimer Disease Alector Inc. 69
Testing effectiveness (Phase 2)Study completedNCT01549834What this trial is testingEvaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 434
Not applicableStudy completedNCT03349320What this trial is testingResponse to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic PolymorphismsWho this might be right forLate Onset Alzheimer Disease Federal University of Minas Gerais 37
Testing effectiveness (Phase 2)Study completedNCT02359552What this trial is testingRasagiline Rescue in Alzheimer's Disease Clinical TrialWho this might be right forAlzheimer's Disease The Cleveland Clinic 50
Very early researchStudy completedNCT06489015What this trial is testingRecombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical TrialWho this might be right forAlzheimer's Disease (AD) Shenzhen Protgen Co., Ltd. 30
Not applicableUnknownNCT03773016What this trial is testingTouchscreen Technology and Art for People With Dementia in Care HomesWho this might be right forMild DementiaModerate Dementia University of Nottingham 12
Large-scale testing (Phase 3)UnknownNCT01094340What this trial is testingThalidomide for Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Banner Health 20
Not applicableStudy completedNCT00211159What this trial is testingOmegAD (Omega-3 and Alzheimer's Disease)Who this might be right forAlzheimer's Disease Karolinska University Hospital 204
Testing effectiveness (Phase 2)Study completedNCT01350362What this trial is testingEfficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer's Disease Noscira SA 306
Early research (Phase 1)Study completedNCT02624778What this trial is testingLY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADWho this might be right forAlzheimer Disease Eli Lilly and Company 61
Testing effectiveness (Phase 2)Ended earlyNCT01676935What this trial is testingThis is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 349
Testing effectiveness (Phase 2)Study completedNCT00948259What this trial is testingSafety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s DiseaseWho this might be right forAlzheimer´s Disease Noscira SA 30
Testing effectiveness (Phase 2)Ended earlyNCT00960531What this trial is testingA Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Pfizer 160
Testing effectiveness (Phase 2)Study completedNCT03748706What this trial is testingPTI-125 for Mild-to-moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer Disease Pain Therapeutics 13
Testing effectiveness (Phase 2)Ended earlyNCT00606476What this trial is testingAAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 194
Testing effectiveness (Phase 2)UnknownNCT00174525What this trial is testingSafety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pharmacology Research Institute
Not applicableStudy completedNCT04570215What this trial is testingDigital Interventions in Neuro-Rehabilitation: Gotcha!Who this might be right forDementiaAlzheimer DiseaseAnomia University College, London 48
Large-scale testing (Phase 3)Study completedNCT05686044What this trial is testingA Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADWho this might be right forAlzheimer Disease Annovis Bio Inc. 351
Not applicableStudy completedNCT01937221What this trial is testingNovel Retinal Imaging Biomarkers in Early Alzheimer's DiseaseWho this might be right forMild Cognitive ImpairmentMild to Moderate Cognitive Impairment Duke University 60
Large-scale testing (Phase 3)Study completedNCT02079246What this trial is testingLong-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease H. Lundbeck A/S 1,463